Item

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

Coombes, R. C.
; 
Howell, S.
; 
Lord, S. R.
; 
Kenny, L.
; 
Mansi, J.
; 
Mitri, Z.
; 
Palmieri, C.
; 
Chap, L. I.
; 
Richards, P.
; 
Gradishar, W.
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Coombes, R. C.
Howell, S.
Lord, S. R.
Kenny, L.
Mansi, J.
Mitri, Z.
Palmieri, C.
Chap, L. I.
Richards, P.
Gradishar, W.
Sardesai, S.
Melear, J.
O'Shaughnessy, J.
Ward, P.
Chalasani, P.
Arkenau, T.
Baird, R. D.
Jeselsohn, R.
Ali, S.
Clack, G.
Bahl, A.
McIntosh, S.
Krebs, M. G.
Affiliation
Imperial College, South Kensington, London, UK. Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK. Guy's and St Thomas' NHS Foundation Trust, London, UK. OHSU Knight Cancer Institute, Portland, OR, USA. University of Liverpool, Liverpool, UK. University of California, Los Angeles, CA, USA. Blue Ridge Cancer Center, Salem, VA, USA. Northwestern University, Chicago, IL, USA. US Oncology Research, OHC, Cincinnati, OH, USA. Baylor University Medical Center, Texas Oncology, Dallas, TX, USA. University of Arizona Cancer Center, Tucson, AZ, USA. Sarah Cannon Research Institute, London, UK. Cancer Research UK Cambridge Centre, Cambridge, UK. Dana-Farber Cancer Institute, Boston, MA, USA. Carrick Therapeutics, Dublin, Ireland. Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk.
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Other
Citation
Coombes RC, Howell S, Lord SR, Kenny L, Mansi J, Mitri Z, et al. Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications. 2025 Mar 6;16(1):2242. PubMed PMID: 40050276. Pubmed Central PMCID: PMC11885804. Epub 2025/03/07. eng.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627531
Embedded videos